Digital therapeutics hold great potential to improve health outcomes and lower costs. But with thousands of new digital health solutions hitting the market, even the most innovative ones will get lost if they are not able to prove their impact on outcomes. There is a growing need for proof—and it all starts with generating evidence. Evidation Health is leading the charge in generating the evidence needed to enable broader adoption by payers, providers and pharmaceutical companies. In this session, they will share:

  • How digital health entrepreneurs can drive richer, evidence-based conversations with healthcare stakeholders

  • Examples of innovative healthcare companies that are quantifying real life across populations at scale

  • Novel applications of digital biomarkers, critical in the move towards value-based care